Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (44)
Juan Antonio Paniagua & Antonio Vidal-Puig. 2023. The Diabetes Textbook. The Diabetes Textbook
217
245
.
Stuart A Morgan, Laura L Gathercole, Zaki K Hassan-Smith, Jeremy Tomlinson, Paul M Stewart & Gareth G Lavery. (2022) 11β-HSD1 contributes to age-related metabolic decline in male mice. Journal of Endocrinology 255:3, pages 117-129.
Crossref
Crossref
Daria Kupczyk, Renata Studzińska, Renata Kołodziejska, Szymon Baumgart, Martyna Modrzejewska & Alina Woźniak. (2022) 11β-Hydroxysteroid Dehydrogenase Type 1 as a Potential Treatment Target in Cardiovascular Diseases. Journal of Clinical Medicine 11:20, pages 6190.
Crossref
Crossref
Angelique Kragl, Janosch Schoon, Ana Tzvetkova, Christoph Wenzel, Martina Blaschke, Wolfgang Böcker, Heide Siggelkow & Mladen V. Tzvetkov. (2022) Effects of HSD11B1 knockout and overexpression on local cortisol production and differentiation of mesenchymal stem cells. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Juan Antonio Paniagua González & Antonio Vidal-Puig. 2019. The Diabetes Textbook. The Diabetes Textbook
185
213
.
Chien-Feng Li, Ting-Ting Liu, Jui-Chu Wang, Shih-Chen Yu, Yen-Yang Chen, Fu-Min Fang, Wan-Shan Li & Hsuan-Ying Huang. (2018) Hydroxysteroid 11-Beta Dehydrogenase 1 Overexpression with Copy-Number Gain and Missense Mutations in Primary Gastrointestinal Stromal Tumors. Journal of Clinical Medicine 7:11, pages 408.
Crossref
Crossref
André Tchernof, Dannick Brochu, Ina Maltais‐Payette, Mohamed Fouad Mansour, Geneviève B. Marchand, Anne‐Marie Carreau & Jordanna Kapeluto. 2011. Comprehensive Physiology. Comprehensive Physiology
1253
1290
.
Ekaterina V. Artemova. (2017) Synthesis, activation and deactivation of glucocorticoids. The biological role of cortisol in metabolic disorders. Obesity and metabolism 14:2, pages 48-52.
Crossref
Crossref
Craig L. Doig, Rachel S. Fletcher, Stuart A. Morgan, Emma L. McCabe, Dean P. Larner, Jeremy W. Tomlinson, Paul M. Stewart, Andrew Philp & Gareth G. Lavery. (2017) 11β-HSD1 Modulates the Set Point of Brown Adipose Tissue Response to Glucocorticoids in Male Mice. Endocrinology 158:6, pages 1964-1976.
Crossref
Crossref
Stuart A Morgan, Zaki K Hassan-Smith, Craig L Doig, Mark Sherlock, Paul M Stewart & Gareth G Lavery. (2016) Glucocorticoids and 11β-HSD1 are major regulators of intramyocellular protein metabolism. Journal of Endocrinology 229:3, pages 277-286.
Crossref
Crossref
André Tchernof, Mohamed Fouad Mansour, Mélissa Pelletier, Marie-Michèle Boulet, Mélanie Nadeau & Van Luu-The. (2015) Updated survey of the steroid-converting enzymes in human adipose tissues. The Journal of Steroid Biochemistry and Molecular Biology 147, pages 56-69.
Crossref
Crossref
Petros Constantinopoulos, Marina Michalaki, Anastasia Kottorou, Ioannis Habeos, Agathoklis Psyrogiannis, Fotios Kalfarentzos & Venetsana Kyriazopoulou. (2015) Cortisol in tissue and systemic level as a contributing factor to the development of metabolic syndrome in severely obese patients. European Journal of Endocrinology 172:1, pages 69-78.
Crossref
Crossref
Heather D Ritter & Christopher R Mueller. (2014) Expression microarray identifies the unliganded glucocorticoid receptor as a regulator of gene expression in mammary epithelial cells. BMC Cancer 14:1.
Crossref
Crossref
Mouna Zerradi, Julie Dereumetz, Marie-Michèle Boulet & André Tchernof. (2014) Androgens, body fat Distribution and Adipogenesis. Current Obesity Reports 3:4, pages 396-403.
Crossref
Crossref
Stuart A. Morgan, Emma L. McCabe, Laura L. Gathercole, Zaki K. Hassan-Smith, Dean P. Larner, Iwona J. Bujalska, Paul M. Stewart, Jeremy W. Tomlinson & Gareth G. Lavery. (2014) 11β-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess. Proceedings of the National Academy of Sciences 111:24.
Crossref
Crossref
Jong Han Lee, Zhanguo Gao & Jianping Ye. (2013) Regulation of 11β-HSD1 expression during adipose tissue expansion by hypoxia through different activities of NF-κB and HIF-1α. American Journal of Physiology-Endocrinology and Metabolism 304:10, pages E1035-E1041.
Crossref
Crossref
C. D. Pereira, I. Azevedo, R. Monteiro & M. J. Martins. (2012)
11
β
‐Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus
. Diabetes, Obesity and Metabolism 14:10, pages 869-881.
Crossref
Crossref
F. Atalar, B. Vural, C. Ciftci, A. Demirkan, G. Akan, B. Susleyici-Duman, D. Gunay, B. Akpinar, E. Sagbas, U. Ozbek & A.S. Buyukdevrim. (2012) 11β-hydroxysteroid dehydrogenase type 1 gene expression is increased in ascending aorta tissue of metabolic syndrome patients with coronary artery disease. Genetics and Molecular Research 11:3, pages 3122-3132.
Crossref
Crossref
Ana Tiganescu, Elizabeth A. Walker, Rowan S. Hardy, Andrew E. Mayes & Paul M. Stewart. (2011) Localization, Age- and Site-Dependent Expression, and Regulation of 11β-Hydroxysteroid Dehydrogenase Type 1 in Skin. Journal of Investigative Dermatology 131:1, pages 30-36.
Crossref
Crossref
JULIA LEPENIES, MARTIN HEWISON, PAUL M STEWART & MARCUS QUINKLER. (2010) Renal PPARγ mRNA expression increases with impairment of renal function in patients with chronic kidney disease. Nephrology 15:7, pages 683-691.
Crossref
Crossref
Laura L. Gathercole & Paul M. Stewart. (2010) Targeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetes. The Journal of Steroid Biochemistry and Molecular Biology 122:1-3, pages 21-27.
Crossref
Crossref
Alain Veilleux, Philippe Y. Laberge, Jacques Morency, Suzanne Noël, Van Luu-The & André Tchernof. (2010) Expression of genes related to glucocorticoid action in human subcutaneous and omental adipose tissue. The Journal of Steroid Biochemistry and Molecular Biology 122:1-3, pages 28-34.
Crossref
Crossref
Nicholas Michael Morton. (2010) Obesity and corticosteroids: 11β-Hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease. Molecular and Cellular Endocrinology 316:2, pages 154-164.
Crossref
Crossref
René Baudrand, Cristian A. Carvajal, Arnoldo Riquelme, Mauricio Morales, Nancy Solis, Margarita Pizarro, Alex Escalona, Camilo Boza, Gustavo Pérez, Angélica Domínguez, Marco Arrese & Carlos E. Fardella. (2009) Overexpression of 11β-Hydroxysteroid Dehydrogenase Type 1 in Hepatic and Visceral Adipose Tissue is Associated with Metabolic Disorders in Morbidly Obese Patients. Obesity Surgery 20:1, pages 77-83.
Crossref
Crossref
Margaret Castro, Lucila Leico Elias, Paula Conde Lamparelli Elias & Ayrton Custodio Moreira. 2011. Cushing's Syndrome. Cushing's Syndrome
1
20
.
Alain Veilleux, Caroline Rhéaume, Marleen Daris, Van Luu-The & André Tchernof. (2009) Omental Adipose Tissue Type 1 11β-Hydroxysteroid Dehydrogenase Oxoreductase Activity, Body Fat Distribution, and Metabolic Alterations in Women. The Journal of Clinical Endocrinology & Metabolism 94:9, pages 3550-3557.
Crossref
Crossref
Karine Blouin, Alain Veilleux, Van Luu-The & André Tchernof. (2009) Androgen metabolism in adipose tissue: Recent advances. Molecular and Cellular Endocrinology 301:1-2, pages 97-103.
Crossref
Crossref
Roland H. Stimson, Jonas Andersson, Ruth Andrew, Doris N. Redhead, Fredrik Karpe, Peter C. Hayes, Tommy Olsson & Brian R. Walker. (2009) Cortisol Release From Adipose Tissue by 11β-Hydroxysteroid Dehydrogenase Type 1 in Humans. Diabetes 58:1, pages 46-53.
Crossref
Crossref
André Tchernof. 2010. Diabetes in Women. Diabetes in Women
1
24
.
Malgorzata Wamil, Ruth Andrew, Karen E. Chapman, Jonathan Street, Nicholas M. Morton & Jonathan R. Seckl. (2008) 7-Oxysterols Modulate Glucocorticoid Activity in Adipocytes through Competition for 11β-Hydroxysteroid Dehydrogenase Type. Endocrinology 149:12, pages 5909-5918.
Crossref
Crossref
Iwona J. Bujalska, Kylie N. Hewitt, David Hauton, Gareth G. Lavery, Jeremy W. Tomlinson, Elizabeth A. Walker & Paul M. Stewart. (2008) Lack of Hexose-6-Phosphate Dehydrogenase Impairs Lipid Mobilization from Mouse Adipose Tissue. Endocrinology 149:5, pages 2584-2591.
Crossref
Crossref
Li Sun, Julie A. Stenken, Amy Y. Yang, Jamie J. Zhao & Donald G. Musson. (2007) An in vitro microdialysis methodology to study 11β-hydroxysteroid dehydrogenase type 1 enzyme activity in liver microsomes. Analytical Biochemistry 370:1, pages 26-37.
Crossref
Crossref
M.-C. Vantyghem, S. Marcelli-Tourvieille, F. Defrance & J.-L. Wemeau. (2007) 11β-hydroxystéroïde déshydrogénases. Avancées récentes. Annales d'Endocrinologie 68:5, pages 349-356.
Crossref
Crossref
Lydia E Kuo, Joanna B Kitlinska, Jason U Tilan, Lijun Li, Stephen B Baker, Michael D Johnson, Edward W Lee, Mary Susan Burnett, Stanley T Fricke, Richard Kvetnansky, Herbert Herzog & Zofia Zukowska. (2007) Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nature Medicine 13:7, pages 803-811.
Crossref
Crossref
Malin Hult, Naeem Shafqat, Björn Elleby, Doreen Mitschke, Stefan Svensson, Margareta Forsgren, Tjeerd Barf, Jerk Vallgårda, Lars Abrahmsen & Udo Oppermann. (2006) Active site variability of type 1 11β-hydroxysteroid dehydrogenase revealed by selective inhibitors and cross-species comparisons. Molecular and Cellular Endocrinology 248:1-2, pages 26-33.
Crossref
Crossref
Michael Loffler, Martin Bilban, Mark Reimers, Werner Waldhäusl & Thomas M. Stulnig. (2006)
Blood Glucose-Lowering Nuclear Receptor Agonists Only Partially Normalize Hepatic Gene Expression in
db/db
Mice
. Journal of Pharmacology and Experimental Therapeutics 316:2, pages 797-804.
Crossref
Crossref
Marcus QuinklerDaniel ZehnderKevin S. EardleyJulia LepeniesAlexander J. HowieSusan V. HughesPaul CockwellMartin HewisonPaul M. Stewart. (2005) Increased Expression of Mineralocorticoid Effector Mechanisms in Kidney Biopsies of Patients With Heavy Proteinuria. Circulation 112:10, pages 1435-1443.
Crossref
Crossref
Kristin L. Morris & Michael B. Zemel. (2012)
1, 25‐Dihydroxyvitamin D
3
Modulation of Adipocyte Glucocorticoid Function
. Obesity Research 13:4, pages 670-677.
Crossref
Crossref
T Skurk & H Hauner. (2004) Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1. International Journal of Obesity 28:11, pages 1357-1364.
Crossref
Crossref
George A Bray. (2004) The epidemic of obesity and changes in food intake: the Fluoride Hypothesis. Physiology & Behavior 82:1, pages 115-121.
Crossref
Crossref
Björn Elleby, Stefan Svensson, Xiaoqiu Wu, Karin Stefansson, Joakim Nilsson, Dan Hallén, Udo Oppermann & Lars Abrahmsén. (2004) High-level production and optimization of monodispersity of 11β-hydroxysteroid dehydrogenase type 1. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1700:2, pages 199-207.
Crossref
Crossref
Nicholas M. Morton, Janice M. Paterson, Hiroaki Masuzaki, Megan C. Holmes, Bart Staels, Catherine Fievet, Brian R. Walker, Jeffrey S. Flier, John J. Mullins & Jonathan R. Seckl. (2004) Novel Adipose Tissue–Mediated Resistance to Diet-Induced Visceral Obesity in 11β-Hydroxysteroid Dehydrogenase Type 1–Deficient Mice. Diabetes 53:4, pages 931-938.
Crossref
Crossref
P.M. Stewart. (2004) Glucocorticoids, 11-β hydroxysteroid dehydrogenase and glucose metabolism. Annales d'Endocrinologie 65:1, pages 84.
Crossref
Crossref
Karine Blouin, Christian Richard, Chantal Bélanger, Pierre Dupont, Marleen Daris, Philippe Laberge, Van Luu-The & André Tchernof. (2003) Local Androgen Inactivation in Abdominal Visceral Adipose Tissue. The Journal of Clinical Endocrinology & Metabolism 88:12, pages 5944-5950.
Crossref
Crossref